Study analysis · Nutrition reviews · 2026
Probiotics can help preterm babies avoid a deadly gut disease and improve blood sugar in type 2 diabetes — but they may also raise sepsis risk in vulnerable infants, and the benefits depend entirely on the strain.
A huge review of 128 studies found that some probiotics help with certain gut, metabolic, and other conditions, but they are not a cure-all and can be risky for fragile babies.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This is a big summary of many smaller studies where people were randomly assigned to take probiotics or not. It can tell us that some probiotics might help with certain health problems, but it doesn't prove they work for everyone or every condition. We can't say they definitely cause improvement because the studies were different and we only read the short summary.
What’s the bottom line?
Scientists combined many studies to see if probiotics, prebiotics, and synbiotics work for different health problems. They found that some probiotics can help premature babies avoid a serious gut disease and can help people with type 2 diabetes control blood sugar and cholesterol. They also help with gut issues, women's health, and some brain/mental health conditions. But the effects depend on the specific strain and the person. Most are safe, but there is a risk of sepsis in vulnerable babies. The studies varied a lot, so results are not precise.
How strong is this study?
The study is a review of many good studies, which is usually strong evidence. But we only have the short summary, not the full details, so we don't know if the smaller studies were done well. That means we should be careful about trusting the results too much.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 526 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. While the design (umbrella review of SRs/MAs of RCTs) can support causal inference, the abstract-only analysis, substantial heterogeneity, and inability to verify the quality of included reviews and primary RCTs limit the strength of causal conclusions. Effects are strain-specific and condition-specific, so causal claims should be narrow.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information is provided in the abstract; full text is needed to assess potential biases.
The provided text is an abstract only and contains no COI, funding, or author affiliation disclosures. Therefore, conflict of interest and funder involvement cannot be determined from this text alone.
Key takeaways
- 01
Certain probiotics reduce necrotizing enterocolitis in infants (relative risk reduction not specified; absolute risk not reported).
- 02
Certain probiotics improve glycemic control, lipid profiles, and inflammation in type 2 diabetes (effect sizes not reported).
- 03
Benefits also seen in gastrointestinal disorders, gynecological conditions, and some neurological/psychiatric disorders.
- 04
Most biotics well tolerated, but increased risk of sepsis in vulnerable pediatric populations (absolute risk not reported).
- 05
The study does not report absolute risk reductions or increases.
- 06
Therefore, we cannot say how many infants would be spared NEC or how many extra cases of sepsis would occur per 1,000 people.
- 07
The benefits and risks are described qualitatively.
Practical takeaways
Choose probiotics for a specific condition rather than as a general health booster, and look for strains studied for that condition.
The abstract does not specify which strains, doses, or populations; full paper not available. Effects vary by strain, population, and condition.
low confidenceIn preterm or vulnerable infants, use probiotics only under medical supervision because of the noted increased sepsis risk.
Absolute risk increase and number needed to harm are not reported in the abstract; full paper not available.
low confidenceWhy this study matters
Probiotics reduce NEC in preterm infants — but by how much?
Certain probiotic strains reduce necrotizing enterocolitis (NEC) in infants, according to an umbrella review of 128 systematic reviews and meta-analyses of RCTs. The abstract does not report the relative risk reduction or absolute risk reduction (e.g., how many babies need treatment to prevent one case).
NEC is a devastating disease for premature babies, so any prevention is important. But without absolute numbers, parents and doctors can't weigh benefits against risks like sepsis.
Type 2 diabetes: blood sugar, cholesterol, and inflammation improve
Certain probiotics improve glycemic control, lipid profiles, and inflammation in patients with type 2 diabetes mellitus, per the umbrella review. The abstract does not report effect sizes or absolute improvements in HbA1c, LDL cholesterol, or inflammatory markers.
Millions of people with type 2 diabetes look for non-drug ways to manage their condition. This suggests some probiotics may help, but the lack of numbers means we can't say how much.
Benefits beyond the gut: IBS, IBD, constipation, gynecological, and some brain/mental conditions
The review found benefits for gastrointestinal disorders (irritable bowel syndrome, inflammatory bowel disease, constipation), gynecological conditions, and some neurological and psychiatric disorders. Effects varied by strain, population, and condition.
Probiotics are often marketed for general gut health, but this suggests they may also affect women's health and even brain/mental health — though the evidence is not uniform.
Safety warning: increased sepsis risk in vulnerable pediatric populations
Most biotics were well tolerated, but safety concerns such as increased risk of sepsis in vulnerable pediatric populations were noted. The abstract does not report absolute risk increases or number of cases.
Probiotics are often perceived as completely safe, so a potential sepsis risk in fragile infants is a critical caveat for parents and clinicians.
Huge heterogeneity: 128 reviews but limited comparability
Data from 128 systematic reviews and meta-analyses were synthesized, but substantial heterogeneity across studies, particularly in network meta-analyses, limited comparability. The review calls for standardization in future trials.
This explains why probiotic research often seems contradictory: studies use different strains, doses, populations, and outcomes. It's a call for better science before firm recommendations.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists combined many studies to see if probiotics, prebiotics, and synbiotics work for different health problems. They found that some probiotics can help premature babies avoid a serious gut disease and can help people with type 2 diabetes control blood sugar and cholesterol. They also help with gut issues, women's health, and some brain/mental health conditions. But the effects depend on the specific strain and the person. Most are safe, but there is a risk of sepsis in vulnerable babies. The studies varied a lot, so results are not precise.
Research results
Certain probiotics reduce necrotizing enterocolitis in infants (relative risk reduction not specified; absolute risk not reported). Certain probiotics improve glycemic control, lipid profiles, and inflammation in type 2 diabetes (effect sizes not reported). Benefits also seen in gastrointestinal disorders, gynecological conditions, and some neurological/psychiatric disorders. Most biotics well tolerated, but increased risk of sepsis in vulnerable pediatric populations (absolute risk not reported).
What this means - more context
The study does not report absolute risk reductions or increases. Therefore, we cannot say how many infants would be spared NEC or how many extra cases of sepsis would occur per 1,000 people. The benefits and risks are described qualitatively.
To synthesize recent evidence on efficacy and safety of prebiotics, probiotics, and synbiotics to inform clinical application and future research.
Umbrella review of 128 systematic reviews and meta-analyses of RCTs found that certain probiotics reduce necrotizing enterocolitis in infants and improve glycemic control, lipid profiles, and inflammation in type 2 diabetes. Benefits were also observed in gastrointestinal, gynecological, and some neurological/psychiatric disorders. Effects varied by strain, population, and condition. Most biotics were well tolerated, but increased sepsis risk was noted in vulnerable pediatric populations. Substantial heterogeneity limited comparability.
Methods Used
Literature searches in PubMed, Embase, and Web of Science identified systematic reviews and meta-analyses of RCTs published since 2023. Data extracted included effect estimates from pairwise and network meta-analyses. Data from 128 systematic reviews and meta-analyses were synthesized.
Main Finding
Biotics offer promising but selective clinical benefits depending on condition and population. Certain probiotics reduce necrotizing enterocolitis in infants (relative risk reduction not specified; absolute risk not reported) and improve glycemic control, lipid profiles, and inflammation in type 2 diabetes (effect sizes not reported). Benefits were also seen in gastrointestinal, gynecological, and some neurological/psychiatric disorders. Most biotics are well tolerated, but increased sepsis risk in vulnerable pediatric populations was noted (absolute risk not reported). Standardization in future trials is essential.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Substantial heterogeneity across studies limits comparability
- •No effect sizes or absolute risks reported in abstract
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Practical Takeaways
Choose probiotics for a specific condition rather than as a general health booster, and look for strains studied for that condition.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 526 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Systematic Review
Subject
Lower probability
on the GRADE evidence scale
This is a big summary of many smaller studies where people were randomly assigned to take probiotics or not. It can tell us that some probiotics might help with certain health problems, but it doesn't prove they work for everyone or every condition. We can't say they definitely cause improvement because the studies were different and we only read the short summary.
Strengths
- Umbrella review of 128 systematic reviews and meta-analyses
- Included only recent SRs/MAs of RCTs (since 2023)
- PROSPERO registered (CRD420251010116)
Weaknesses
- Full methodology not available - based on abstract only
- Quality of included systematic reviews and meta-analyses not assessed in abstract
- Substantial heterogeneity, particularly in network meta-analyses
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
Scientists combined many studies to see if probiotics, prebiotics, and synbiotics work for different health problems. They found that some probiotics can help premature babies avoid a serious gut disease and can help people with type 2 diabetes control blood sugar and cholesterol. They also help with gut issues, women's health, and some brain/mental health conditions. But the effects depend on the specific strain and the person. Most are safe, but there is a risk of sepsis in vulnerable babies. The studies varied a lot, so results are not precise.
Research results
Certain probiotics reduce necrotizing enterocolitis in infants (relative risk reduction not specified; absolute risk not reported). Certain probiotics improve glycemic control, lipid profiles, and inflammation in type 2 diabetes (effect sizes not reported). Benefits also seen in gastrointestinal disorders, gynecological conditions, and some neurological/psychiatric disorders. Most biotics well tolerated, but increased risk of sepsis in vulnerable pediatric populations (absolute risk not reported).
What this means - more context
The study does not report absolute risk reductions or increases. Therefore, we cannot say how many infants would be spared NEC or how many extra cases of sepsis would occur per 1,000 people. The benefits and risks are described qualitatively.
To synthesize recent evidence on efficacy and safety of prebiotics, probiotics, and synbiotics to inform clinical application and future research.
Umbrella review of 128 systematic reviews and meta-analyses of RCTs found that certain probiotics reduce necrotizing enterocolitis in infants and improve glycemic control, lipid profiles, and inflammation in type 2 diabetes. Benefits were also observed in gastrointestinal, gynecological, and some neurological/psychiatric disorders. Effects varied by strain, population, and condition. Most biotics were well tolerated, but increased sepsis risk was noted in vulnerable pediatric populations. Substantial heterogeneity limited comparability.
Methods Used
Literature searches in PubMed, Embase, and Web of Science identified systematic reviews and meta-analyses of RCTs published since 2023. Data extracted included effect estimates from pairwise and network meta-analyses. Data from 128 systematic reviews and meta-analyses were synthesized.
Main Finding
Biotics offer promising but selective clinical benefits depending on condition and population. Certain probiotics reduce necrotizing enterocolitis in infants (relative risk reduction not specified; absolute risk not reported) and improve glycemic control, lipid profiles, and inflammation in type 2 diabetes (effect sizes not reported). Benefits were also seen in gastrointestinal, gynecological, and some neurological/psychiatric disorders. Most biotics are well tolerated, but increased sepsis risk in vulnerable pediatric populations was noted (absolute risk not reported). Standardization in future trials is essential.
Confidence Level
Limited - based on abstract only, full methodology not available
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Substantial heterogeneity across studies limits comparability
- •No effect sizes or absolute risks reported in abstract
No biological mechanisms were identified in this study. This may be an epidemiological, observational, or survey-based study that reports associations rather than proposing causal biological pathways.
Practical Takeaways
Choose probiotics for a specific condition rather than as a general health booster, and look for strains studied for that condition.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 526 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
Systematic Review
Subject
Lower probability
on the GRADE evidence scale
This is a big summary of many smaller studies where people were randomly assigned to take probiotics or not. It can tell us that some probiotics might help with certain health problems, but it doesn't prove they work for everyone or every condition. We can't say they definitely cause improvement because the studies were different and we only read the short summary.
Strengths
- Umbrella review of 128 systematic reviews and meta-analyses
- Included only recent SRs/MAs of RCTs (since 2023)
- PROSPERO registered (CRD420251010116)
Weaknesses
- Full methodology not available - based on abstract only
- Quality of included systematic reviews and meta-analyses not assessed in abstract
- Substantial heterogeneity, particularly in network meta-analyses
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study is a review of many good studies, which is usually strong evidence. But we only have the short summary, not the full details, so we don't know if the smaller studies were done well. That means we should be careful about trusting the results too much.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
0 / 100
- Randomizationrandomization unclear
- Blindingblinding unclear
- Control groupno control group
- Sample sizeno sample size reported
- Follow-upno follow-up reported
100 / 100
23 / 100
- P-valuesno p-values reported
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 526 / 100
Probability of being correct
The highest quality evidence. Systematic reviews and meta-analyses that pool randomized controlled trials, giving the most reliable summary of experimental evidence.
This design can establish causation. While the design (umbrella review of SRs/MAs of RCTs) can support causal inference, the abstract-only analysis, substantial heterogeneity, and inability to verify the quality of included reviews and primary RCTs limit the strength of causal conclusions. Effects are strain-specific and condition-specific, so causal claims should be narrow.
COI Unknown
Could not determine conflict of interest status
No conflict of interest or funding information is provided in the abstract; full text is needed to assess potential biases.
The provided text is an abstract only and contains no COI, funding, or author affiliation disclosures. Therefore, conflict of interest and funder involvement cannot be determined from this text alone.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
2 researchersIf this is your work, this is how we attribute it on Fit Body Science. Tung Hoang is listed as the lead author.